Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,581 Million (Small Cap)
54.00
NA
1.34%
-0.03
4.11%
1.94
Revenue and Profits:
Net Sales:
183 Million
(Quarterly Results - Jun 2026)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.69%
0%
23.69%
6 Months
-7.55%
0%
-7.55%
1 Year
13.76%
0%
13.76%
2 Years
41.92%
0%
41.92%
3 Years
-33.51%
0%
-33.51%
4 Years
-14.11%
0%
-14.11%
5 Years
-25.64%
0%
-25.64%
Teyi Pharmaceutical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.32%
EBIT Growth (5y)
-8.81%
EBIT to Interest (avg)
12.33
Debt to EBITDA (avg)
0.33
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.39
Tax Ratio
2.74%
Dividend Payout Ratio
91.74%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.06%
ROE (avg)
9.04%
Valuation key factors
Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
2.22
EV to EBIT
58.06
EV to EBITDA
33.26
EV to Capital Employed
2.26
EV to Sales
4.82
PEG Ratio
0.70
Dividend Yield
1.56%
ROCE (Latest)
3.90%
ROE (Latest)
4.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
183.50
196.00
-6.38%
Operating Profit (PBDIT) excl Other Income
25.40
25.20
0.79%
Interest
1.20
1.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.30
6.40
-17.19%
Operating Profit Margin (Excl OI)
36.70%
40.10%
-0.34%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is -6.38% vs 31.46% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is -17.19% vs 198.46% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
915.70
684.60
33.76%
Operating Profit (PBDIT) excl Other Income
147.30
91.20
61.51%
Interest
4.60
5.90
-22.03%
Exceptional Items
0.00
-11.60
100.00%
Consolidate Net Profit
81.70
20.50
298.54%
Operating Profit Margin (Excl OI)
85.20%
39.90%
4.53%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 33.76% vs -35.41% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 298.54% vs -91.90% in Dec 2024
About Teyi Pharmaceutical Group Co., Ltd. 
Teyi Pharmaceutical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






